Evidence map›Paper›PMID 39759157›Full record

ArticleResearch (Washington, D.C.)2022

Inhibition of Cancer Cell Migration and Glycolysis by Terahertz Wave Modulation via Altered Chromatin Accessibility.

Lan Sun, Yangmei Li, Yun Yu, Peiliang Wang, Shengquan Zhu, Kaijie Wu, Yan Liu, Ruixing Wang, Li Min, Chao Chang

Abstract read
In one paragraph

Article in Research (Washington, D.C.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Advances in Terahertz Biophysics and Chemistry.Research (Washington, D.C.) · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lan SunInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.ORCID https://orcid.org/0000-0002-3317-2154
Yangmei LiInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.
Yun YuInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.
Peiliang WangInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.
Shengquan ZhuDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Kaijie WuInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.
Yan LiuInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.
Ruixing WangInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.
Li MinDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.ORCID https://orcid.org/0000-0001-9595-5536
Chao ChangInnovation Laboratory of Terahertz Biophysics, National Innovation Institute of Defense Technology, Beijing 100071 China.ORCID https://orcid.org/0000-0002-4081-1583

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis and metabolic disorders contribute to most cancer deaths and are potential drug targets in cancer treatment. However, corresponding drugs inevitably induce myeloid suppression and gastrointestinal toxicity. Here, we report a nonpharmaceutical and noninvasive electromagnetic intervention technique that exhibited long-term inhibition of cancer cells. Firstly, we revealed that optical radiation at the specific wavelength of 3.6

Identifiers

PMID39759157
PMCPMC11697589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.